Obermeyer Wealth Partners’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-40,816
| Closed | -$4.05M | – | 137 |
|
|
2019
Q3 | $4.05M | Sell |
40,816
-169,506
| -81% | -$16.1M | 0.37% | 37 |
|
|
2019
Q2 | $19.4M | Sell |
210,322
-38,047
| -15% | -$3.61M | 1.75% | 29 |
|
|
2019
Q1 | $23.4M | Sell |
248,369
-40,349
| -14% | -$3.53M | 2.2% | 24 |
|
|
2018
Q4 | $18.5M | Sell |
288,718
-33,038
| -10% | -$2.44M | 1.87% | 26 |
|
|
2018
Q3 | $28.8M | Sell |
321,756
-28,364
| -8% | -$2.51M | 2.43% | 23 |
|
|
2018
Q2 | $27.8M | Sell |
350,120
-164,205
| -32% | -$13.6M | 2.47% | 23 |
|
|
2018
Q1 | $45.9M | Sell |
514,325
-161,453
| -24% | -$15.5M | 4.16% | 7 |
|
|
2017
Q4 | $70.5M | Sell |
675,778
-11,576
| -2% | -$1.31M | 6.13% | 1 |
|
|
2017
Q3 | $100M | Sell |
687,354
-15,603
| -2% | -$2.13M | 8.68% | 1 |
|
|
2017
Q2 | $91.3M | Sell |
702,957
-71,863
| -9% | -$8.81M | 8.1% | 1 |
|
|
2017
Q1 | $96.4M | Sell |
774,820
-47,829
| -6% | -$5.72M | 8.88% | 1 |
|
|
2016
Q4 | $95.2M | Sell |
822,649
-55,502
| -6% | -$6.18M | 9.11% | 1 |
|
|
2016
Q3 | $91.8M | Sell |
878,151
-19,507
| -2% | -$2.11M | 8.8% | 1 |
|
|
2016
Q2 | $88.5M | Sell |
897,658
-125,650
| -12% | -$13M | 8.81% | 1 |
|
|
2016
Q1 | $102M | Sell |
1,023,308
-23,640
| -2% | -$2.43M | 9.49% | 1 |
|
|
2015
Q4 | $125M | Sell |
1,046,948
-44,967
| -4% | -$5.2M | 11.44% | 1 |
|
|
2015
Q3 | $118M | Sell |
1,091,915
-6,174
| -0.6% | -$766K | 12.44% | 1 |
|
|
2015
Q2 | $127M | Sell |
1,098,089
-52,982
| -5% | -$6.06M | 10.84% | 1 |
|
|
2015
Q1 | $133M | Sell |
1,151,071
-44,017
| -4% | -$5.26M | 10.86% | 1 |
|
|
2014
Q4 | $134M | Buy |
+1,195,088
| New | +$126M | 12.1% | 1 |
|
|
2013
Q3 | – | Sell |
-360
| Closed | -$21K | – | 362 |
|
|
2013
Q2 | $21K | Buy |
+360
| New | +$21.7K | 0.01% | 198 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Obermeyer Wealth Partners's CELG Position: Q4 2019 in Review
Obermeyer Wealth Partners sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 40,816 shares — an estimated $4.05M sold.
Obermeyer Wealth Partners first reported a position in CELG in Q2 2013 and held it in 21 quarters. The position peaked at $134M in Q4 2014. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Obermeyer Wealth Partners reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Obermeyer Wealth Partners sold 40,816 Celgene Corp shares in Q4 2019, an estimated $4.05M.
- Obermeyer Wealth Partners first reported a position in Celgene Corp in Q2 2013 and held it in 21 quarters.
- Obermeyer Wealth Partners's Celgene Corp position peaked at $134M in Q4 2014.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Obermeyer Wealth Partners's 13F filing for Q4 2019, filed 3 Feb 2020.